These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 182419)

  • 1. The hormonal and metabolic basis of experimental obesity.
    Assimacopoulos-Jeannet F; Jeanrenaud B
    Clin Endocrinol Metab; 1976 Jul; 5(2):337-65. PubMed ID: 182419
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of liver lipid metabolism in experimental obesity [proceedings].
    Jeanrenaud B; Freychet P; Assimacopoulos-Jeannet F; le Marchand Y; Karakash C
    Biochem Soc Trans; 1977; 5(4):890-4. PubMed ID: 199498
    [No Abstract]   [Full Text] [Related]  

  • 3. [Conditioning of hyperglycemia and hyperinsulinemia in genetically obese mice through resistance to insulin].
    Genes SG
    Fiziol Zh; 1974; 20(2):265-72. PubMed ID: 4595869
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipid metabolism in genetic models of obesity.
    York DA
    Proc Nutr Soc; 1975 Dec; 34(3):249-55. PubMed ID: 174122
    [No Abstract]   [Full Text] [Related]  

  • 5. Vagotomy diminishes obesity in cafeteria rats by decreasing cholinergic potentiation of insulin release.
    Balbo SL; Ribeiro RA; Mendes MC; Lubaczeuski C; Maller AC; Carneiro EM; Bonfleur ML
    J Physiol Biochem; 2016 Dec; 72(4):625-633. PubMed ID: 27351887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The possible role of adipose tissue in insulin resistance and in the physiopathology of obese diabetics].
    Guy-Grand B; Bour H
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):81-92. PubMed ID: 4606004
    [No Abstract]   [Full Text] [Related]  

  • 7. Bezafibrate on lipids and glucose metabolism in obese diabetic Otsuka Long-Evans Tokushima fatty rats.
    Jia D; Yamamoto M; Otani M; Otsuki M
    Metabolism; 2004 Apr; 53(4):405-13. PubMed ID: 15045684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity.
    Watson E; Hahm S; Mizuno TM; Windsor J; Montgomery C; Scherer PE; Mobbs CV; Salton SR
    Endocrinology; 2005 Dec; 146(12):5151-63. PubMed ID: 16141392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypothalamus and metabolic control.
    Frohman LA
    Pathobiol Annu; 1971; 1():353-72. PubMed ID: 4950383
    [No Abstract]   [Full Text] [Related]  

  • 10. Obesity: changes in lipid metabolism and the role of insulin.
    Nestel P; Goldrick B
    Clin Endocrinol Metab; 1976 Jul; 5(2):313-35. PubMed ID: 182418
    [No Abstract]   [Full Text] [Related]  

  • 11. Improved glucose and lipid metabolism in genetically obese mice lacking aP2.
    Uysal KT; Scheja L; Wiesbrock SM; Bonner-Weir S; Hotamisligil GS
    Endocrinology; 2000 Sep; 141(9):3388-96. PubMed ID: 10965911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin receptor deficiency in genetic and acquired obesity.
    Soli AH; Kahn CR; Neville DM; Roth J
    J Clin Invest; 1975 Oct; 56(4):769-80. PubMed ID: 169296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T
    Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energy fuel and hormonal profile in experimental obesities.
    Jeanrenaud B
    Experientia Suppl; 1983; 44():57-76. PubMed ID: 6357849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-cell stimulus - secretion coupling defects in rodent models of obesity.
    Chan CB
    Can J Physiol Pharmacol; 1995 Oct; 73(10):1414-24. PubMed ID: 8748932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of streptozotocin on glucose metabolism, insulin response, and adiposity in ob/ob mice.
    Batchelor BR; Stern JS; Johnson PR; Mahler RJ
    Metabolism; 1975 Jan; 24(1):77-91. PubMed ID: 122852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization.
    Kotani K; Peroni OD; Minokoshi Y; Boss O; Kahn BB
    J Clin Invest; 2004 Dec; 114(11):1666-75. PubMed ID: 15578099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taurine prevents fat deposition and ameliorates plasma lipid profile in monosodium glutamate-obese rats.
    Nardelli TR; Ribeiro RA; Balbo SL; Vanzela EC; Carneiro EM; Boschero AC; Bonfleur ML
    Amino Acids; 2011 Oct; 41(4):901-8. PubMed ID: 21042817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal obesities.
    Jeanrenaud B
    Ann Nutr Aliment; 1979; 33(1):27-38. PubMed ID: 382957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.